Occult spondyloarthritis in inflammatory bowel disease

Francesca Bandinelli1, Mirko Manetti2, Lidia Ibba-Manneschi2

  • 1Department of Experimental and Clinical Medicine, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. bandin@hotmail.it.

Clinical Rheumatology
|September 11, 2015
PubMed

Insights

Spondyloarthritis (SpA) is common in inflammatory bowel disease (IBD) but often missed. Early detection using imaging like ultrasound and X-rays can prevent long-term joint damage and improve quality of life for IBD patients.

Area of Science:

  • Rheumatology
  • Gastroenterology
  • Immunology

Background:

  • Spondyloarthritis (SpA) is a frequent extra-intestinal manifestation in inflammatory bowel disease (IBD).
  • The link between IBD and SpA involves microbiome abnormalities and genetic factors, but pathogenesis remains unclear.
  • Clinically asymptomatic SpA in IBD patients is increasingly recognized.

Purpose of the Study:

  • To highlight the underestimation of SpA prevalence in IBD patients.
  • To discuss the role of imaging in detecting occult SpA.
  • To emphasize the need for multidisciplinary approaches in managing SpA in IBD.

Main Methods:

  • Review of clinical studies and imaging techniques.
  • Focus on enthesis ultrasound (US) and sacroiliac joint X-ray examinations.
  • Exploration of diagnostic approaches and biomarkers for occult joint manifestations.

Main Results:

  • Occult enthesitis and sacroiliitis are found in a high percentage of IBD patients via imaging.
  • Current diagnostic tools and biomarkers lack definitive results for screening.
  • Integrated multidisciplinary approaches are crucial for accurate diagnosis and treatment.

Conclusions:

  • Routine use of inexpensive imaging like US and X-ray is recommended for evaluating occult SpA in IBD.
  • Early detection and management can prevent disability and improve quality of life.
  • Further research is needed to refine diagnostic strategies and biomarkers.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
920
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
950
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
759